We are live on ! Find out more
MET.PRE icon

MetLife Inc 5.625% Series E Preferred Stock
MET.PRE

2 hedge funds and large institutions have $7.33M invested in MetLife Inc 5.625% Series E Preferred Stock in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0.06% less ownership

Funds ownership: 0.95% → 0.89% (-0.06%)

7% less capital invested

Capital invested by funds: $7.87M → $7.33M (-$537K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MC
Middleton & Co
Massachusetts
+$253K

Top Sellers

Rank Fund Capital Flow
1
CGH
Crossmark Global Holdings
Texas
-$406K
2
SAM
Selway Asset Management
-$309K
Name Holding Trade Value Shares
Change 		Change in
Stake
CGH
1
Crossmark Global Holdings
Texas
$7.07M -$406K -16,093 -5%
MC
2
Middleton & Co
Massachusetts
$255K +$253K +10,000 New
SAM
3
Selway Asset Management
– -$309K -12,000 Closed

MET.PRE Hedge Fund Activity: Q2 2022 in Review

2 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in MetLife Inc 5.625% Series E Preferred Stock (MET.PRE) for Q2 2022, worth a combined $7.33M — down 6.8% from $7.87M a quarter earlier.

Fund positioning in MET.PRE was balanced in Q2 2022: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.

The largest buyer was Middleton & Co, opening a new position worth an estimated $253K. The largest seller was Crossmark Global Holdings, cutting an estimated $406K.

  • 2 institutional investors held MetLife Inc 5.625% Series E Preferred Stock (MET.PRE) as of Q2 2022, unchanged from Q1 2022.
  • Funds reported $7.33M of MetLife Inc 5.625% Series E Preferred Stock stock for Q2 2022, down 6.8% quarter-over-quarter.
  • 1 fund opened new MetLife Inc 5.625% Series E Preferred Stock positions in Q2 2022 and 1 closed out, a net change of 0 holders.
  • The largest MetLife Inc 5.625% Series E Preferred Stock buyer in Q2 2022 was Middleton & Co, an estimated $253K added.
  • The largest MetLife Inc 5.625% Series E Preferred Stock seller in Q2 2022 was Crossmark Global Holdings, an estimated $406K sold.

Based on aggregated 13F filings for Q2 2022.